Lung Cancer Trial, Recruiting NCT05596578 Sponsor: Luzerner Kantonsspital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05596578
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a surgical procedure to remove part of a lung (such as a lobe, two lobes, or a smaller segment) due to non-small cell lung cancer (NSCLC), where the tumour was smaller than 3 cm
  • People whose surgery included collecting lymph node samples from specific locations inside the lung (stations 12, 13, and 14)
  • People whose surgery included removal of lymph nodes from specific areas near where the lung meets the airway (stations 10 and 11) during the procedure
  • People whose surgery achieved a complete removal of the cancer with no cancer cells detected at the edges of the removed tissue (known as an R0 resection)

Who may not be able to join:

  • People who have had a previous lung cancer diagnosis, or who have been found to have a second lung cancer at the same time as their current one
  • People whose cancer has been found to have spread to certain lymph nodes in the chest (a finding doctors call pN2)
  • People who required removal of an entire lung during surgery
  • People whose surgery did not fully remove the cancer, meaning cancer cells were still found at or near the surgical margins
  • People whose cancer has been found to have spread to other parts of the body beyond the lung (known as M1 or distant metastasis)
  • People who received treatment such as chemotherapy or radiation before their surgery (known as neoadjuvant treatment)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +410412051111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Luzerner Kantonsspital
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2024

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

N1; VPI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov